Swedish Orphan Biovitrum AB - Company Profile
Powered by 
All the sales intelligence you need on Swedish Orphan Biovitrum AB in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Swedish Orphan Biovitrum AB fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Swedish Orphan Biovitrum AB.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Swedish Orphan Biovitrum AB (Sobi) manufactures and sells products for the treatment of rare diseases. Robust patient engagement: Unite4Rare, diversified geographical presence, and focus on R&D are its major strengths, even as Increasing Operating Costs is a cause for concern. Growing market for chronic kidney diseases, contracts and agreements, and regulatory approvals could provide growth opportunities to the company. However, growing parallel trade, stringent regulations, and competitive pressure pose challenges to the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer